PHARMACEUTICAL COMPOSITION IN FORM OF SOLUTE FOR INTRAVENOUS AND INTRAMUSCULAR INJECTION AND ITS PRODUCTION PROCESS Russian patent published in 2017 - IPC A61K31/44 A61K47/20 A61K9/08 A61J3/00 

FIELD: pharmacology.

SUBSTANCE: solute comprises 6-methyl-2-ethylpyridin-3-ol salt (2S)-2-acetglutamine acid in a pharmacologic effective dose in the function of the active ingredient, and also additive agents. The solute comprises the solvent in the function of the additive agents, more specifically the water for injections, the stabilizator - sodium metabisulfite, the corrector pH - 1M chlorohydric acid solution or 1M sodium hydroxide solution to achieve pH from 3.5 to 4.5.

EFFECT: obtaining final dosage form in the form of the solute, the quality of which meets all the requirements applicable to agents that are meant to be used in clinic.

12 cl, 4 tbl, 4 ex